VIENNA—Latest research on breast cancer prevention was reported at the 20125 St Gallen breast cancer conference in a session concluded by Jack Cuzick, PhD, Director of the Wolfson Institute of Prevent
VIENNA—Latest research on breast cancer prevention was reported at the 20125 St Gallen breast cancer conference in a session concluded by Jack Cuzick, PhD, Director of the Wolfson Institute of Preventive Medicine and Head of the Centre for Cancer Prevention at Queen Mary, University of London. Oncology Times reporter Sarah Maxwell began by asking him about the IBIS I and II studies—using drugs affecting the estrogen receptor—and about IBIS III using aromatase inhibitor, bisphosphonate and metformin for primary prevention.